Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treating epilepsy in tuberous sclerosis with everolimus: getting closer.

Literature DB >> 24940159

Treating epilepsy in tuberous sclerosis with everolimus: getting closer.

John W Miller.

Abstract

Entities: Chemical Disease

Year: 2014 PMID： 24940159 PMCID： PMC4038280 DOI： 10.5698/1535-7597-14.3.143

Source DB: PubMed Journal: Epilepsy Curr ISSN： 1535-7511 Impact factor: 7.500

× No keyword cloud information.

11 in total

1. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.

Authors: Darcy A Krueger; Marguerite M Care; Katherine Holland; Karen Agricola; Cynthia Tudor; Prajakta Mangeshkar; Kimberly A Wilson; Anna Byars; Tarek Sahmoud; David Neal Franz
Journal: N Engl J Med Date: 2010-11-04 Impact factor: 91.245

2. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.

Authors: Darcy A Krueger; Angus A Wilfong; Katherine Holland-Bouley; Anne E Anderson; Karen Agricola; Cindy Tudor; Maxwell Mays; Christina M Lopez; Mi-Ok Kim; David Neal Franz
Journal: Ann Neurol Date: 2013-09-10 Impact factor: 10.422

3. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.

Authors: J Heitman; N R Movva; M N Hall
Journal: Science Date: 1991-08-23 Impact factor: 47.728

4. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex.

Authors: David Neal Franz; Jennifer Leonard; Cynthia Tudor; Gail Chuck; Marguerite Care; Gopalan Sethuraman; Argirios Dinopoulos; George Thomas; Kerry R Crone
Journal: Ann Neurol Date: 2006-03 Impact factor: 10.422

Review 5. Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy.

Authors: Robin C C Ryther; Michael Wong
Journal: Curr Neurol Neurosci Rep Date: 2012-08 Impact factor: 5.081

6. Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma.

Authors: Darcy A Krueger; Marguerite M Care; Karen Agricola; Cindy Tudor; Maxwell Mays; David Neal Franz
Journal: Neurology Date: 2013-01-16 Impact factor: 9.910

7. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

Authors: Ling-Hui Zeng; Lin Xu; David H Gutmann; Michael Wong
Journal: Ann Neurol Date: 2008-04 Impact factor: 10.422

8. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

Authors: David Neal Franz; Elena Belousova; Steven Sparagana; E Martina Bebin; Michael Frost; Rachel Kuperman; Olaf Witt; Michael H Kohrman; J Robert Flamini; Joyce Y Wu; Paolo Curatolo; Petrus J de Vries; Vicky H Whittemore; Elizabeth A Thiele; James P Ford; Gaurav Shah; Helene Cauwel; David Lebwohl; Tarek Sahmoud; Sergiusz Jozwiak
Journal: Lancet Date: 2012-11-14 Impact factor: 79.321